Nuvectis Pharma, Inc.
NASDAQ:NVCT
5.37 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -4.153 | -4.428 | -4.171 | -6.622 | -5.881 | -5.708 | -4.049 | -6.696 | -5.877 | -3.569 | -2.943 | -2.261 | -4.668 | -5.938 | -0.023 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| -2.583 | 1.262 | 1.296 | 1.22 | 1.133 | 0.95 | 1.402 | 0.482 | 0.559 | 0.51 | 0.156 | 0.185 | 0.136 | 1.571 | 0 |
| Change In Working Capital
| 1.337 | 0.146 | -1.483 | 1.552 | 1.504 | 0.675 | -2.13 | 2.698 | 0.894 | 0.516 | -0.289 | 1.009 | 0.106 | 0.356 | 0.023 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0.415 | 0.087 | -1.012 | 0.021 | 0 | -0.293 | -0.814 | 0 | 0 | 0 | 0.542 | 1.479 | 0.106 | 0 | 0 |
| Other Working Capital
| 0.922 | 0.059 | -0.471 | 1.531 | 1.504 | 0.675 | -2.13 | 2.698 | -0.001 | 0.516 | -0.831 | -0.47 | 0.106 | 0.356 | 0 |
| Other Non Cash Items
| 2.995 | 1.175 | 2.308 | 1.199 | 1.133 | 0.95 | 1.402 | 0.482 | 0.002 | 0.51 | 0.156 | 0.185 | 0.136 | 1.571 | 0.023 |
| Operating Cash Flow
| -2.404 | -3.02 | -4.358 | -3.85 | -3.244 | -4.083 | -4.777 | -3.516 | -4.424 | -2.543 | -3.076 | -1.067 | -4.426 | -4.011 | 0 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 1.507 | 1.727 | 4.849 | 0.901 | 1.126 | 3.262 | 0.252 | -0.131 | 15.879 | -0.578 | 16 | 0 | 4.021 | 11.225 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.05 | -0.055 | -0.153 | 0.016 | -0.423 | 9.953 | 0.252 | -0.131 | -1.387 | -0.578 | -1.973 | 0 | 4.021 | 11.225 | 0 |
| Financing Cash Flow
| 1.457 | 1.672 | 4.696 | 0.917 | 0.703 | 13.215 | 0.252 | -0.131 | 14.492 | -0.578 | 14.027 | 0 | 4.021 | 11.225 | 0 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.947 | -1.348 | 0.338 | -2.933 | -2.541 | 9.132 | -4.525 | -3.647 | 10.068 | -3.121 | 10.951 | -1.067 | -0.405 | 7.214 | 0 |
| Cash At End Of Period
| 17.169 | 18.116 | 19.464 | 19.126 | 22.059 | 24.6 | 15.468 | 19.993 | 23.64 | 13.572 | 16.693 | 5.742 | 6.809 | 7.214 | 0 |